Viewing Study NCT02613403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-22 @ 7:26 PM
Study NCT ID: NCT02613403
Status: TERMINATED
Last Update Posted: 2024-05-22
First Post: 2015-11-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis View
None Hepatitis C View
None Digestive System Diseases View
None Flaviviridae Infections View
None Hepatitis, Viral, Human View
None Liver Diseases View
None RNA Virus Infections View
None Virus Diseases View
Keywords: